November 21, 2017 5:33pm

As the sector opens up, slips at the mid-day and closes down

 

While the iShares Nasdaq Biotechnology ETF (IBB) closed up +0.77%

Earnings season is winding down and most companies have missed expectations and that's a negative for the sector

 

Daily pre-open indications: 0 hit and 5 miss (still made $)

Quarterly results: IMUC

 

How right does one have to be? You could and should be reading this review of the day’s share pricing activity?

Is the truth so hard to fathom – that’s why my readership has grown exponentially!

 

Tuesday’s results have implications to Wednesday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

Henry’omics:

From the pre-open’s newsletter, “the current sector resistance … Transparency and guidance by managements can escort investors out of the current maze of negative sentiment! Investors want to know, will forgive if there’s a substance beyond the words of the message.”

Not every company is open to being transparent, about their weaknesses, vulnerabilities and mistakes, and OUR universe has more than many detractors. But in MY view, admitting weakness is strength — both personally and for an organization.

I feel a responsibility to put out everything oy there about the sector!

There is always a disproportionate and a distorted risk to the downside.

My objective is to achieve balance in dispersing intelligence that is factual to disperse the hype of many of the sector’s “usual suspects”.

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The open was positive with an A/DL of 24/14 and 5 flats ;

·         The mid-day was negative with an A/DL of 17/23 and 3 flats;

·         The close was negative with an A/DL of 19/22 and 2 flats;

 

Daily pre-open indication re-cap: 0 hit and 5 miss

  • AxoGen (AXGN) closed up +$1.85 – miss;
  • Bellicum Pharmaceuticals (BLCM) closed down -$0.11 – miss;
  • bluebird bio (BLUE) closed up +$1.85 – miss;
  • BioLife Solutions (BLFS) closed up +$0.04 – miss;
  • MiMedx (MDXG) closed down -$0.10 – miss;

 

 

Some of MY working trend lines or indications:

… The greatest volume to the downside:  NWBO, MDXG, JUNO, CYTX and XON

… Upside volume was weighted to:  SGMO, IMUC, VCEL, VSTM and AXGN

… Biggest $ downside: JUNO (-$0.29), CLLS (-$0.20), XON (-$0.13), FATE (-$0.12) and BLCM (-$0.11)

… Largest $ upside:  BLUE (+$1.85), AXGN (+$1.85), RGNX (+$1.30), KOOL (+$0.67) and VCEL (+$0.45)

… Flat:  OSIR and RENE.L

 

 

Daily analytics:

U.S. stocks closed higher Tuesday after a round of solid corporate earnings. All three benchmark equity indexes hit fresh records.

·         The NASDAQ showed the biggest gains, rising 72 points, or 1%, to 6862.

·         The Dow rose 161 points to 23591.

·         The S&P 500 was up by 17 points, or 0.7%, to 2599.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Tuesday traded at 9.72, down -8.54% …

  • Monday traded at 10.65, down -6.82% after Friday traded at 11.33, down -2.81% after Thursday traded at 11.79, down -1.34% after Wednesday traded at 13.13, up +13.29% and Tuesday traded at 11.59, up +0.78% …

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Tuesday was up +1.05%

·         Monday +0.72%

·         Friday +0.43%

·         Thursday +1.24%

·         Wednesday -0.40%

·         Last Tuesday -0.27%

 

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Tuesday was up +0.77%

·         Monday -0.93%

·         Friday +0.13%

·         Thursday +1.49%

·         Wednesday +0.39%

·         Last Tuesday -1.62%

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %

·         Tuesday’s decliners ranged from -0.14% <BSTG -$0.00> to -21.03% <NWBO -$0.06> in 22 equities;

·         Monday’s decliners ranged from -0.13% < QURE -$0.02> to -6.43% <MDXG -$0.76> in 24 equities;

·         Friday’s decliners ranged from -0.33% <QURE -$0.05 > to -0.65% <BSTG -$0.005> in 15 equities;

·         Thursday’s decliners ranged from -0.34% < SGMO-$0.05> to -9.36% <AXGN -$2.30> in 13 equities;

·         Wednesday’s decliners ranged from -0.24% <XON -$0.03> to -12.96% <CAPR -$0.35> in 22 equities;

·         Last Tuesday’s decliners ranged from -0.25% <BCLI -$0.01> to -8.06% <CUR -$0.08> in 30 equities;

Versus

 

… Look at the percentage’s (%) and spreads …

·         Tuesday’s gainers ranged from +0.03% <IMUC +0.00 > to +20.74% <KOOL +$0.67> in 19 equities;

·         Monday’s gainers ranged from +0.46% < FATE +$0.02 > to +32.42% <NWBO +$0.07> in 19 equities;

·         Friday’s gainers ranged from +0.17% <SGMO +$0.02 > to +18.34% <NWBO +$0.034> in 26 equities;

·         Thursday’s gainers ranged from +0.25% <BCLI +$0.01> to +15.19% <VTGN +$0.12> in 28 equities;

·         Wednesday’s gainers ranged from +0.40% <AXGN +$0.10> to +13.57% <SGMO +$1.75> in 18 equities;

·         Last Tuesday’s gainers ranged from +0.61% <NWB) -$0.001> to +6.71% <FCSC +$0.11> in 11 equities;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.